Transcatheter aortic valve implantation: Role of multimodality cardiac imaging

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 1, 2010, Pages 113-123

  Delgado, Victoria ^a   Ng, Arnold Ct ^a   Shanks, Miriam ^a   Van Der Kley, Frank ^a   Schuijf, Joanne D ^a   Van De Veire, Nico Rl ^a   Kroft, Lucia ^a   Roos, Albert De ^a   Schalij, Martin J ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

echocardiography; magnetic resonance; multidetector computed tomography; transcatheter valve implantation; valve in valve

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; CLINICAL ASSESSMENT; DISEASE SEVERITY; FEASIBILITY STUDY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; REVIEW; SAFETY; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER AORTIC VALVE PROSTHESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AORTA VALVE STENOSIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METHODOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION;

AORTIC VALVE STENOSIS; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949517356     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.135     Document Type: Review

References (38)

1. Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005-1011 (2006).
2. lung B, Cachier A, Baron G et al. Decision- making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26, 2714-2720 (2005).
3. Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114, e84-e231 (2006).
4. Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230-268 (2007).
5. Grube E, Buellesfeld L, Mueller R et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the corevalve revalving system. Circ. Cardiovas. Intervent. 1, 167-175 (2008).
6. Vahanian A, Alfieri O, Al-Attar N et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio- Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 29, 1463-1470 (2008).
7. Chiam PT, Ruiz CE. Percutaneous transcatheter aortic valve implantation: evolution of the technology. Am. HeartJ. 157, 229-242 (2009).
8. Rosengart TK, Feldman T, Borger MA et al. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 117, 1750-1767 (2008).
9. Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol.
10. Himbert D, Descoutures F, Al-Attar N et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J. Am. Coll. Cardiol. 54, 303-311 (2009).
11. Rodes-Cabau J, Dumont E, De LaRochelliere R et al. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. Am. J. Cardiol. 102, 1240-1246 (2008).
12. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J. Am. Coll. Cardiol. 53, 1829-1836 (2009).
13. Webb JG, Altwegg L, Boone RH et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119, 3009-3016 (2009).
14. Piazza N, Grube E, Gerckens U et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve Revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4(2), 242-249 (2008).
15. Kapadia SR, Goel SS, Svensson L et al. Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J. Thorac. Cardiovasc. Surg. 137, 1430-1435 (2009).
16. Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842-850 (2006).
17. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111, 920-925 (2005).
18. Delgado V, Tops LF, Schuijf JD et al. Successful deployment of a transcatheter aortic valve in bicuspid aortic stenosis: role of imaging with computed tomography. Circ. Cardiovasc. Imaging 2, e12-e13 (2009).
19. Zegdi R, Ciobotaru V, Noghin M et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J. Am. Coll. Cardiol. 51, 579-584 (2008).
20. Biner S, Rafique AM, Ray I et al. Aortopathy is prevalent in relatives of bicuspid aortic valve patients. J. Am. Coll. Cardiol. 53, 2288-2295 (2009).
21. Caruthers SD, Lin SJ, Brown P et al. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation 108, 2236-2243 (2003).
22. Pouleur AC, le Polain de Waroux JB, Pasquet A et al. Aortic valve area assessment: multidetector CT compared with cine MR imaging and transthoracic and transesophageal echocardiography. Radiology 244, 745-754 (2007).
23. Burman E, Keegan J, Kilner P. Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement, and corresponding normal values. Circ. Cardiovasc. Imaging 1, 104-113 (2008).
24. Moss RR, Ivens E, Pasupati S et al. Role of echocardiography in percutaneous aortic valve implantation. J. Am. Coll. Cardiol. Imaging 1, 15-24 (2008).
25. Doddamani S, Bello R, Friedman MA et al. Demonstration of left ventricular outflow tract eccentricity by real time 3D echocardiography: implications for the determination of aortic valve area. Echocardiography 24, 860-866 (2007).
26. Doddamani S, Grushko MJ, Makaryus AN et al. Demonstration of left ventricular outflow tract eccentricity by 64-slice multi-detector CT. Int. J. Cardiovasc. Imaging 25, 175-181 (2009).
27. Tops L, Wood D, Delgado V et al. Noninvasive evaluation of the aortic root with computed tomography implications for transcatheter aortic valve replacement. J. Am. Coll. Cardiol. Imaging 1, 321-330 (2008).
28. Auerbach EG, Martin ET. Magnetic resonance imaging of the peripheral vasculature. Am. Heart J. 148, 755-763 (2004).
29. Iozzelli A, D'Orta G, Aliprandi A et al. The value of true-FISP sequence added to conventional gadolinium-enhanced MRA of abdominal aorta and its major branches. Eur. J. Radiol. DOI:10.1016/j.ejrad.2008.09.004 (2008) (Epub ahead of print).
30. Swan JS, Kennell TW, Acher CW et al. Magnetic resonance angiography of aorto-iliac disease. Am. J. Surg. 180, 6-12 (2000).
31. Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third- generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69-76 (2007).
32. Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116, 755-763 (2007).
33. Linke A, Hollriegel R, Walther T et al. Ingrowths of a percutaneously implanted aortic valve prosthesis (CoreValve) in a patient with severe aortic stenosis. Circ. Cardiovas. Intervent. 1, 155-158 (2009).
34. Trepels T, Martens S, Doss M et al. Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 120, e23-e24 (2009).
35. Lefevre T. The SOURCE Registry. Presented at: Transcatheter Cardiovascular Therapeutics. WA, USA, 13 October 2008.
36. Svensson LG, Dewey T, Kapadia S et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann. Thorac. Surg. 86, 46-54 (2008).
37. Walther T. Transapical aortic valve implantation: Traverce Feasibility Study. Presented at: Transcatheter Cardiovascular Therapeutics. WA, USA, 13 October 2008.
38. Laborde JC. Transcatheter aortic valve implantation with the CoreValve ReValving Device. Presented at: Transcatheter Cardiovascular Therapeutics. WA, USA, 13 October 2008.